Shi, Yuankai
474  results:
Search for persons X
?
2

High-Throughput Antigen Microarray Identifies Longitudinal ..:

Dai, Liyuan ; Tan, Qiaoyun ; Li, Lin...
Molecular & Cellular Proteomics.  23 (2024)  5 - p. 100749 , 2024
 
?
4

Efficacy and safety of anlotinib plus penpulimab as second-..:

Zhang, Changgong ; Chen, Jianhua ; Wu, Huijuan...
Cancer Pathogenesis and Therapy.  2 (2024)  4 - p. 268-275 , 2024
 
?
5

Patient-reported outcomes for the phase 3 FURLONG study of ..:

Shi, Yuankai ; Chen, Gongyan ; Wang, Xiang...
The Lancet Regional Health - Western Pacific.  48 (2024)  - p. 101122 , 2024
 
?
 
?
7

The co‐location of CD14+APOE+ cells and MMP7+ tumour cells ..:

Fan, Guangyu ; Xie, Tongji ; Tang, Le...
Clinical and Translational Medicine.  14 (2024)  9 - p. , 2024
 
?
8

Efficacy and safety of utidelone for the treatment of patie..:

Shi, Yuankai ; Chen, Gongyan ; Zhao, Yanqiu..
Cancer Pathogenesis and Therapy.  2 (2024)  2 - p. 103-111 , 2024
 
?
9

Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Mult..:

Shi, Yuankai ; Hu, Xingsheng ; Li, Xingya...
Journal of Thoracic Oncology.  19 (2024)  6 - p. 898-911 , 2024
 
?
13

Mutational variant allele frequency profile as a biomarker ..:

Gao, Ruyun ; Lou, Ning ; Li, Lin...
Journal of Translational Medicine.  22 (2024)  1 - p. , 2024
 
?
 
?
15

Tunlametinib (HL-085) plus vemurafenib in patients with adv..:

Shi, Yuankai ; Han, Xiaohong ; Zhao, Qian...
Experimental Hematology & Oncology.  13 (2024)  1 - p. , 2024
 
1-15